No description

Netherlands Cancer Institute

The Netherlands Cancer Institute was founded in 1913, combining research and patient care focussing solely on cancer. It is the only dedicated cancer centre in the Netherlands and maintains an important role as national and international centre of scientific and clinical expertise, development and training.

We have produced 7 triple negative breast cancer models with primary and xenograft samples for multiple passages. The models are characterized with array CGH, exome sequencing and RNASeq.

The Netherlands Cancer Institute is a member of the EurOPDX Consortium. EurOPDX is supported by the European Union's Horizon 2020 research and innovation program under the grant agreement No. 731105 EDIReX

You are running an old browser version. We recommend updating your browser to its latest version.

More info